CD4
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
13 01 2023
13 01 2023
Historique:
received:
26
05
2022
accepted:
12
12
2022
entrez:
13
1
2023
pubmed:
14
1
2023
medline:
18
1
2023
Statut:
epublish
Résumé
Despite their low abundance in the tumor microenvironment (TME), classical type 1 dendritic cells (cDC1) play a pivotal role in anti-cancer immunity, and their abundance positively correlates with patient survival. However, their interaction with CD4
Identifiants
pubmed: 36639382
doi: 10.1038/s41467-022-35615-5
pii: 10.1038/s41467-022-35615-5
pmc: PMC9839676
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
217Informations de copyright
© 2023. The Author(s).
Références
Immunity. 2017 Nov 21;47(5):848-861.e5
pubmed: 29126798
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3515-9
pubmed: 8170938
Immunity. 2019 Sep 17;51(3):573-589.e8
pubmed: 31474513
Nat Rev Immunol. 2011 Nov 11;11(12):823-36
pubmed: 22076556
Cancer Cell. 2016 Aug 8;30(2):324-336
pubmed: 27424807
J Exp Med. 2000 Dec 18;192(12):1685-96
pubmed: 11120766
Cancer Cell. 2014 Nov 10;26(5):638-52
pubmed: 25446897
Nat Rev Immunol. 2003 Dec;3(12):939-51
pubmed: 14647476
Trends Cancer. 2018 Nov;4(11):784-792
pubmed: 30352680
Cell Rep. 2017 Jan 3;18(1):248-262
pubmed: 28052254
Trends Immunol. 2019 Jul;40(7):559-561
pubmed: 31133464
J Immunol. 2011 Nov 1;187(9):4411-5
pubmed: 21948982
Cancer Cell. 2017 May 8;31(5):711-723.e4
pubmed: 28486109
Front Immunol. 2015 Mar 23;6:129
pubmed: 25852695
Nature. 2017 Nov 23;551(7681):525-528
pubmed: 29107940
Hum Gene Ther Methods. 2014 Oct;25(5):277-87
pubmed: 25143008
Cell Rep. 2016 Jan 26;14(3):586-597
pubmed: 26774484
Blood. 2002 Oct 15;100(8):2858-66
pubmed: 12351396
Ann Oncol. 2013 Oct;24(10):2686-2693
pubmed: 23904461
J Immunol. 2005 Jan 15;174(2):710-7
pubmed: 15634890
Nat Med. 2017 Jan 6;23(1):18-27
pubmed: 28060797
Cell. 2019 Oct 31;179(4):829-845.e20
pubmed: 31675496
Science. 2017 Apr 21;356(6335):
pubmed: 28428369
Cancer Cell. 2019 Feb 11;35(2):238-255.e6
pubmed: 30753825
Nat Rev Immunol. 2014 Aug;14(8):571-8
pubmed: 25033907
Nature. 2020 Aug;584(7822):624-629
pubmed: 32788723
Immunity. 2017 Feb 21;46(2):205-219
pubmed: 28190711
Immunity. 2019 Dec 17;51(6):1059-1073.e9
pubmed: 31757674
Adv Immunol. 2020;148:49-91
pubmed: 33190733
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560
pubmed: 31114875
Nat Med. 2018 Oct;24(10):1550-1558
pubmed: 30127393
Annu Rev Immunol. 2016 May 20;34:93-119
pubmed: 26735697
J Immunother Cancer. 2020 May;8(1):
pubmed: 32461349
J Immunol. 2002 Oct 15;169(8):4094-7
pubmed: 12370335
J Exp Med. 2021 Jan 4;218(1):
pubmed: 33601412
J Immunol. 1994 Feb 15;152(4):1762-73
pubmed: 8120385
Cell. 2021 Oct 14;184(21):5482-5496.e28
pubmed: 34597583
J Exp Med. 1994 Apr 1;179(4):1109-18
pubmed: 8145033
Eur J Immunol. 2021 Aug;51(8):1911-1920
pubmed: 34106465
J Immunol. 2014 Aug 15;193(4):1622-35
pubmed: 25009205
Nat Commun. 2015 Jun 25;6:7458
pubmed: 26109379
J Immunol. 2011 Jun 15;186(12):6848-59
pubmed: 21551364
Nat Commun. 2012 Jul 10;3:948
pubmed: 22781761
Genome Biol. 2018 Dec 19;19(1):224
pubmed: 30567574
Nature. 2020 Apr;580(7802):257-262
pubmed: 32269339
Curr Opin Immunol. 2020 Jun;64:1-8
pubmed: 31927332
Nat Med. 2012 Mar 25;18(4):555-63
pubmed: 22447076
Transl Res. 2016 Feb;168:74-95
pubmed: 26297944
Immunity. 2016 Apr 19;44(4):924-38
pubmed: 27096321
JCI Insight. 2020 Sep 17;5(18):
pubmed: 32841222
Immunology. 2018 May;154(1):3-20
pubmed: 29313948
Immunity. 2019 May 21;50(5):1317-1334.e10
pubmed: 30979687
Nat Rev Immunol. 2018 Oct;18(10):635-647
pubmed: 30057419
J Transl Med. 2010 Jan 15;8:4
pubmed: 20078880
Cell. 2018 Feb 22;172(5):1022-1037.e14
pubmed: 29429633
J Immunol. 2008 Jul 15;181(2):1071-82
pubmed: 18606659